Page 61 - 南京医科大学学报自然科学版
P. 61

第42卷第3期                           南京医科大学学报(自然科学版)
                  2022年3月                   Journal of Nanjing Medical University(Natural Sciences)     ·363 ·


               ·临床研究·

                支架序贯手术与急诊手术对左半结肠癌伴梗阻的疗效对比



                戴晨光 ,赵黎黎 ,范文涛 ,魏宁心 ,叶建新 ,范志宁                      2,3* ,何可心  2,3*
                                                  1
                                         2,3
                                                          1
                      1,2
                               2,3
                苏州大学附属第一医院消化内科,江苏                苏州   215006;南京医科大学第一附属医院消化内镜科,普通外科,江苏                      南京
                1                                            2                                3
                210029
               [摘   要] 目的:本研究旨在比较金属支架置入序贯限期手术(bridge to surgery,BTS)与急诊手术(emergency surgery,ES)对左
                半结肠癌伴急性肠梗阻的疗效。方法:本研究为回顾性研究。纳入2013年5月—2017年12月就诊于苏州大学附属第一医院
                或南京医科大学第一附属医院的左半结肠癌伴急性肠梗阻的患者资料,包括其定期随访结果。本研究中的临床成功定义为外
                科手术后肠功能恢复持续超过30 d,且无并发症或死亡。对一般资料、干预过程和随访结果等进行比较,分析疗效差异,并论
                证影响长期生存情况的危险因素。结果:BTS组短期疗效较好,包括:术中减压干预较少(85.1% vs. 69.6%,P=0.045),减压效果
                更好(64.2% vs. 27.5%,P<0.001),一期吻合率较高(65.7% vs. 17.4%,P<0.001),造瘘率较低(临时造瘘率:34.3% vs. 82.6%;永
                久造瘘率:13.4% vs. 58.7%;P 均<0.001),ICU 入住率较低(10.4% vs. 27.5%,P=0.011),术中并发症较少(3.0% vs. 13.0%,P=
                0.031),以及术后 30 d 死亡率较低(0 vs. 8.7%,P=0.028)。两组在临床成功率(73.1% vs. 63.8%,P=0.240)、总死亡率(53.7% vs.
                64.4%,P=0.247)和中位生存时间(52.0个月 vs. 35.0个月,P=0.121)方面差异无统计学意义。此外,TNM分期Ⅳ期、永久性造瘘
                和术后并发症是影响患者长期生存的独立危险因素。结论:对左半结肠癌伴急性肠梗阻,BTS是安全有效的治疗方法,且对长
                期生存时间无负面影响。BTS可通过减少围手术期并发症、术后30 d死亡率及永久性造瘘以改善短期疗效。
               [关键词] 急性左半结肠癌肠梗阻;自膨式金属支架;序贯治疗;急诊手术
               [中图分类号] R735.3                   [文献标志码] A                       [文章编号] 1007⁃4368(2022)03⁃363⁃08
                doi:10.7655/NYDXBNS20220309



                Stenting as bridge to surgery versus emergency surgery for acute left colonic malignant
                obstruction

                                                                   1
                             1,2
                                                                              1
                                        2,3
                                                      2,3
                DAI Chenguang ,ZHAO Lili ,FAN Wentao ,WEI Ningxin ,YE Jianxin ,FAN Zhining 2,3* ,HE Kexin 2,3*
                                                                                                    2
                1 Department of Gastroenterology,the First Affiliated Hospital of Soochow University,Suzhou 215006;Department of
                                  3
                Digestive Endoscopy,Department of General Surgery,the First Affiliated Hospital of Nanjing Medical University,
                Nanjing 210029,China
               [Abstract] Objective:This retrospective study aims to compare the performance for managing acute left colonic malignant
                obstruction by emergency surgery(ES)or stenting as a bridge to surgery(BTS). Methods:The medical records were collected from
                May 2013 to December 2017 in two tertiary hospitals in Eastern China. Clinical success was defined as resumption of intestinal
                function for 30 days without morbidity or mortality after surgical procedure. All demographics,intervention procedures and follow⁃up
                were analyzed for short⁃term and long⁃term outcomes. Risk factors for long⁃term survival were discussed as well. Results:BTS group
                showed better short⁃term performance,including less intraoperative decompressive intervention(85.1% vs. 69.6%,P=0.045),more
                complete decompression(64.2% vs. 27.5%,P<0.001),more primary anastomosis(65.7% vs. 17.4%,P<0.001),less temporary and
                permanent stoma(34.3% vs. 82.6%,13.4% vs. 58.7%,both P<0.001),less intensive care unit requirement(10.4% vs. 27.5%,P=0.011),
                less intraoperative complications(3.0% vs. 13.0% ,P=0.031)and reduced 30 ⁃ day mortality(0 vs. 8.7% ,P=0.028). No significant
                difference was observed about clinical success(73.1% vs. 63.8%,P=0.240),overall mortality(53.7% vs. 64.4%,P=0.247)or long⁃term
                survival(52.0 months vs. 35.0 months,P=0.121). TNM stage Ⅳ,permanent stoma and postoperative complication were the independent

               [基金项目] 国家自然科学基金青年基金(81700577);江苏省高等学校自然科学研究(18KJB320018);江苏省重点研发计划
               (社会发展)面上项目(BE2018659);江苏省医学重点项目(ZDXKA2016005)
                ∗
                通信作者(Corresponding author),E⁃mail:fanzhining@njmu.edu.cn;hkxstella@njmu.pdu.cn
   56   57   58   59   60   61   62   63   64   65   66